CDKN2A and Alzheimer disease: An early study from Bhat et al. (2012) suggested that p16INK4A-positive astrocytes may increase the risk for sporadic AD, since the prefrontal cortex of AD patients harbors a significant increase of senescent astrocytes expressing p16INK4a and matrix metalloproteinase-1 (MMP-1).